本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

7.02
-0.2300-3.17%
成交量:49.23万
成交额:352.67万
市值:6.14亿
市盈率:-6.74
高:7.32
开:7.24
低:7.00
收:7.25
52周最高:11.40
52周最低:1.87
股本:8,751.10万
流通股本:5,715.62万
量比:0.66
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
净资产收益率:-35.02%
总资产收益率:-23.97%
市净率:2.01
市盈率(LYR):-6.28

数据加载中...

2023/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/27

重要事件披露

8-K - Current report
2023/03/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/02

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2023/01/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

重要事件披露

8-K - Current report